Methyl pyrazolo[1,5-a]pyrimidine-2-carboxylate, 97%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-5-((tert-butoxycarbonyl)amino)pentanoic acid, 97%, 1g

(3,5-Dimethyl-pyrazol-1-yl)-acetic acid, 99.0%, 25g

2-(2,4-Dibromophenyl)acetic acid, 98.0%, 250mg

Spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine], 95+%, 2g

PEG Dithiol 20001g

4,4',4'',4'''-(Pyrene-1,3,6,8-tetrayl)tetrabenzaldehyde, 95%, 5g

Hydrogénocarbonate de potassium, min.99%, Ph.Eur., 500 g, emballage plastique.

(2R,3S,4S,5R)-2-(Acetoxymethyl)-2-azido-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate, 95%, 100mg

[(3-fluorophenyl)methyl](prop-2-en-1-yl)amine, 95.0%, 10g

Glycine, N-2-pyrimidinyl-, methyl ester, 98%, 10g

Methyl 5-(aminomethyl)nicotinate, 95.0%, 250mg

tert-Butyl 4-(hydroxyimino)piperidine-1-carboxylate, 95.0%, 25g